Chargement en cours...
Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines
Background: Risperidone is the only antipsychotic approved in Australia for the management of the behavioural and psychological symptoms of dementia (BPSD). In June 2015, the Australian Government Therapeutic Goods Administration (TGA) amended the indication to restrict use in BPSD to patients with...
Enregistré dans:
| Publié dans: | Pharmacy (Basel) |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6789876/ https://ncbi.nlm.nih.gov/pubmed/31336574 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmacy7030100 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|